Virtual V-BID Summit 2022: Enhancing Equity
On March 23, 2022, the University of Michigan V-BID Center held our 17th annual summit.
Press Release: VBID Elements in Build Back Better Act passed by House of Representatives
Build Back Better Act passed by House of RepresentativesIncludes V-BID Elements On November 19, 2021 the U.S. House of Representatives passed the Build Back Better Act (H.R.5376), which allocates funds to combat climate change, bolster the U.S. social safety net, and expand healthcare. The bill promotes elements of value-based insurance design (V-BID), including pre-deductible coverage and cost sharing cap of $35 month on selected insulin products (Sec. 27001), a $2,000/year cap and even monthly distribution of out-of-pocket costs for Medicare beneficiaries (Sec. 139201 and 139202), and the removal of co-pays for vaccines under Medicare Part D as recommended by ACIP (Sec. 139402). Excerpts from the bill are included below.SEC. 27001. SEC. 726. REQUIREMENTS WITH RESPECT TO COST-SHARING FOR CERTAIN INSULIN PRODUCTS"(a) IN GENERAL.-- for plan years beginning on or after January 1, 2023, a group health plan or health insurance issuer offering group health insurance coverage shall [...]
Monday, December 6, 2021: National Lung Cancer Roundtable Annual Meeting
On Monday, December 6, 2021, V-BID Center director, A. Mark Fendrick, presented at the NLCRT annual meeting.
V-BID Center Update: November 2021
Our November 2021 newsletter features policy developments, literature items, media reports, and events supporting continued momentum for multiple V-BID Center initiatives throughout November.
Tuesday, November 9, 2021: University of Michigan HMP 631 Guest Lecture
On Tuesday, November 9, 2021, V-BID Center director, A. Mark Fendrick, presented to the students of University of Michigan School of Public Health HMP 631.
Press Release: V-BID Highlighted in CMMI Strategy
October 20, 2021– the Centers for Medicare and Medicaid Services Innovation Center (CMMI) has released a white paper detailing its strategic direction for the next decade.
Tuesday, October 26, 2021: COA Payer Exchange Summit
On Tuesday, October 26, 2021, V-BID Center director, Dr. A. Mark Fendrick, spoke at the Community Oncology Alliance 2021 virtual Payer Exchange Summit.
Thursday, October 21, 2021: Better Medicare Alliance Summit
On Thursday, October 21, 2021, V-BID Center director, Dr. A. Mark Fendrick, spoke at the 2021 BMA Summit on a panel discussing value-based care.
Press Release: Employers Increase Patient Access to Preventive Care for Chronic Conditions
New NPC-funded research by the Employee Benefit Research Institute (EBRI) has found that many employers would like to further broaden pre-deductible coverage for medications and health services used to treat common chronic conditions.
2023 Sponsorship Opportunities
The V-BID Center is accepting sponsorship inquiries for 2023.
Tuesday, October 5, 2021: University of Michigan Alpha Epsilon Delta
On Tuesday, October 5, 2021, V-BID Center director, Dr. A. Mark Fendrick, presented to the University of Michigan chapter of Alpha Epsilon Delta, a pre-health society.
V-BID Center Update: Enhancing Health Equity and the ACA Preventive Services Mandate
Our September 2021 newsletter features policy developments, literature items, media reports, and events supporting continued momentum for multiple V-BID Center initiatives throughout September.
Thursday, September 30, 2021: Smarter Health Care Coalition & AHIP Panel Discussion on Chronic Disease Coverage
On Wednesday, September 29, 2021, V-BID Center director, Dr. A. Mark Fendrick, spoke at a chronic health care briefing, hosted by America's Health Insurance Plans (AHIP) and the Smarter Health Care Coalition (SHCC).
Tuesday, September 21, 2021: Osher Lifelong Learning Institute Lecture
On Tuesday, September 21, 2021, V-BID Center director, Dr. A. Mark Fendrick, virtually presented to the Osher Lifelong Learning Institute (OLLI) Futurescape of Medicine series.
Tuesday, August 17, 2021: Avera Board of Directors Meeting
On Tuesday, August 17, 2021, V-BID Center director, Dr. A. Mark Fendrick, presented to the Avera Board of Directors.